Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 536
Recruiting: 295
Ph III recruiting: 36
Growth YoY: +3.8%
Industry share: 29%
Top sponsor: Fudan University
Termination share: 45.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (216)

clinicaltrialsPublishedShowing 1–50 of 660 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05007106	MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)	completed	Phase 2	611	Merck Sharp & Dohme LLCINDUSTRY	15	Sep 28, 2026	clinicaltrials
NCT07152782	T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis(THUNDER)	recruiting	Phase 2	202	Fudan UniversityOTHER	1	Sep 28, 2026	clinicaltrials